Free Trial

Galera Therapeutics (GRTX) SEC Filings & 10K Form

Galera Therapeutics logo
$0.03 +0.00 (+12.73%)
(As of 12/20/2024 03:47 PM ET)

Recent Galera Therapeutics SEC Filings

DateFilerForm TypeView
12/20/2024
3:42 PM
Galera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
6:17 AM
Galera Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/15/2024
4:25 PM
Galera Therapeutics (Filer)
Form NT 10-Q
10/18/2024
7:05 AM
Galera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
6:38 AM
Galera Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
09/04/2024
6:01 AM
Galera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
6:00 AM
Galera Therapeutics (Filer)
Form DEF 14A
08/23/2024
6:00 AM
Galera Therapeutics (Filer)
Form PRE 14A
08/20/2024
3:45 PM
Galera Therapeutics (Issuer)
Sorensen Mel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
11:52 AM
Galera Therapeutics (Subject)
Sorensen Mel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
6:30 AM
Galera Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
6:05 AM
Galera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
6:10 AM
Galera Therapeutics (Subject)
Form 425
08/08/2024
6:00 AM
Galera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:02 AM
Galera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
6:00 AM
Galera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
9:25 AM
Galera Therapeutics (Subject)
Soffer Rochel (Filed by)
Form SC 13G
05/16/2024
9:26 AM
Galera Therapeutics (Subject)
Schneid Yair (Filed by)
Form SC 13G/A
05/16/2024
9:26 AM
ALPHA PHARMA Investments LLC (Reporting)
Galera Therapeutics (Issuer)
Soffer Rochel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/13/2024
6:30 AM
Galera Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
6:05 AM
Galera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
3:07 PM
Galera Therapeutics (Filer)
Form 8-A12B
05/01/2024
4:02 PM
Galera Therapeutics (Issuer)
Schneid Yair (Reporting)
Form 4/A
04/16/2024
3:39 PM
ALPHA PHARMA Investments LLC (Filed by)
Galera Therapeutics (Subject)
Form SC 13G
04/03/2024
7:08 AM
Altamont Pharmaceutical Holdings, LLC (Filed by)
Galera Therapeutics (Subject)
Form SC 13G/A
04/01/2024
8:36 PM
Altamont Pharmaceutical Holdings, LLC (Reporting)
Galera Therapeutics (Issuer)
Pearson Mark E. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
03/28/2024
6:30 AM
Galera Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
6:06 AM
Galera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
6:31 AM
Galera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
5:57 PM
Galera Therapeutics (Subject)
Sofinnova Venture Partners IX, L.P. (Filed by)
Form SC 13D/A
01/16/2024
5:11 PM
Galera Therapeutics (Issuer)
Schneid Yair (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:35 AM
Galera Therapeutics (Subject)
GSA CAPITAL PARTNERS LLP (Filed by)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GRTX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners